World Vaccine Congress Europe 2024

位置: Fira de Barcelona Montjuïc, Barcelona, Spain

日期:

活動詳細資訊:

Join Novotech at the World Vaccine Congress, October 29-31, 2024, in Barcelona, Spain, where global leaders in vaccine R&D will collaborate to drive innovation.

With extensive global expertise across more than 4,000 clinical projects, spanning Phase I-IV and bioequivalence studies, Novotech’s Vaccine-Specific Operating Model is designed to accelerate study startup and execution, ensuring speed and efficiency for your vaccine trials.

Schedule a meeting with our experts, Jan Rezulski, Director of Business Development, and Nikki Miller, Senior Therapeutic Strategy Manager, directly through the event networking app. Don't miss the opportunity to connect with us in Barcelona!

Nikki will also be presenting alongside Brayden Fraser, Chief Development Officer, Emeritus Research on the topic "Rapid Vaccine Solutions — Selecting Australia as a Location for Vaccine Clinical Trials."

We look forward to exploring how Novotech can support your vaccine clinical development needs. 

本次活動已圓滿結束

誠摯感謝您在本次活動中對Novotech的關注。活動雖已落幕,但我們的專家團隊仍將持續為委託方提供全方位支援,協助推動各階段的臨床開發。

是否有任何疑問,或希望與我們進一步洽談?

歡迎諮詢臨床開發專家

攜手同行

Novotech

Diana Gheorghi

Novotech
Business Development Manager
Novotech

Nikki Miller

Novotech
資深治療策略經理
加上來自我們 Novotech 中國、客戶關係經營、Novotech 藥物開發諮詢、以及美國和歐洲商務發展團隊的高階團隊成員